ImmunoGen, Inc. (IMGN): Price and Financial Metrics
IMGN Price/Volume Stats
| Current price | $31.23 | 52-week high | $31.25 |
| Prev. close | $31.23 | 52-week low | $3.61 |
| Day low | $31.22 | Volume | 48,606,800 |
| Day high | $31.25 | Avg. volume | 8,778,325 |
| 50-day MA | $29.35 | Dividend yield | N/A |
| 200-day MA | $19.00 | Market Cap | 8.32B |
IMGN Stock Price Chart Interactive Chart >
ImmunoGen, Inc. (IMGN) Company Bio
Immunogen develops targeted anticancer therapeutics. The Company's ADC technology uses tumor-targeting antibodies to deliver an ImmunoGen cell-killing agent specifically to cancer cells. The company was founded in 1981 and is based in Waltham, Massachusetts.
IMGN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IMGN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 671.11% |
| 5-year | 586.37% |
| YTD | N/A |
| 2024 | 0.00% |
| 2023 | 497.78% |
| 2022 | -33.15% |
| 2021 | 15.04% |
| 2020 | 26.35% |